healthcare

In this episode, Wilson Asset Management's Tobias Yao and Tyndall Asset Management's Tim Johnston analyse five small-cap healthcare stocks.

IPOs are down in volume but there are still some interesting prospects, according to this accounting firm's mid-year report.

Mark Arnold shares some stocks that bolstered his team's small-cap growth strategy last financial year and some other consistent performers.

Should investors nibble on a defensive market darling thats tumbled almost 10% in two days?

As Warren Buffett said in an interview in 1999, “the inescapable fact is that the value of an asset, whatever its character, cannot over the long term grow faster than...

The best opportunities are found when you don't follow the herd.

Eleanor Swanson may have picked funds management over a medical degree, but healthcare still has a place in her top picks.

Nanosonics has lived in the shadow of giants like Cochlear for years. Can several near-term growth levers propel the company to new heights?

One of Australia's premier mid-caps has handed down its first-half results. But has it managed to surprise the market yet again?

Antares’ Andrew Hamilton believes the market is missing some key drivers for the global leader in hearing implants.

Australia’s healthcare darling delivered solid results and continued to outflank its competitors on Tuesday.

The most-tipped large cap stocks return for the 8th year. Find out which stocks made your top 10 and which prodigals returned from hiatus.

Financial markets have been heavily distorted in the last couple of years. Early in 2020, we saw the shortest recession in recorded history, which closely followed...

Historically, healthcare has been an all-weather sector, with stocks that can compound earnings over the cycle. The pandemic reversed this trend for the ASX 200...

Sean, Alan, Dan and the Australian Eagle team, now running The Montgomery Fund, and The Montgomery Fund alongside me as co-PM, have held quality healthcare...

If anyone had a good time during the COVID-19 pandemic, it was the healthcare sector. It was its time to shine. Investors were flocking to the door.  The companies...

The healthcare sector is not homogeneous, its companies and sub-sectors are diverse. In contrast, the business activities and products of most banks look similar and...

While healthcare was clearly the lifeblood of the Aussie market over the last decade, the last two years have seen many of these long-term compounders barely register...

So far in 2022, the defensive nature of health care has been the sector’s dominant story, with the S&P 500® Health Care sector returning -5.7% for the year compared...

Investors are becoming increasingly aware of the major themes – or gigatrends – dominating our times and even private market investors are in. Urs Wietlisbach,...